Bluefish Pharmaceuticals
Manufacturing · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Gävlegatan 22, Stockholm, Stockholm, 113...Phone Number
+46 851911600Website
www.bluefishpharma.comRevenue
$20.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Bluefish Pharmaceuticals
Bluefish Pharmaceuticals, established in Sweden, specializes in providing affordable generic medications across Europe. The company is dedicated to ensuring quality pharmaceuticals remain accessible, focusing on market needs and efficiency to optimize investments and minimize development time. With a diverse portfolio of over 80 products, Bluefish targets pharmacies, wholesalers, and governmental and private institutions, emphasizing collaboration with manufacturing partners to maintain competitive pricing and high standards. Their vision is to empower individuals and healthcare providers with reliable solutions, shaping the future of healthcare through strategic partnerships and sustainable practices.Explore more
Bluefish Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bluefish Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Bluefish Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Bluefish Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Bluefish Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Bluefish Pharmaceuticals has new funding data
Check if Bluefish Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Bluefish Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Bluefish Pharmaceuticals
Bluefish Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Bluefish Pharmaceuticals
Find 3 more new buyers
Company Profile Activity
Activity Insights
Bluefish Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bluefish Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bluefish Pharmaceuticals.
Bluefish Pharmaceuticals Tech Stack
A closer look at the technologies used by Bluefish Pharmaceuticals
Bluefish Pharmaceuticals News & Media
Erik Ekman Appointed New CEO in Bluefish
ERIK EKMAN IS APPOINTED NEW CEO FOR BLUEFISH PHARMACEUTICALS AB Erik Ekman becomes the new CEO of Bluefish Pharmaceuticals. Erik will take up the position of CEO during the spring 2022 since Berit Lindholm has announced to the Board that she is leaving Bluefish Pharmaceuticals joining a non-competitive organisation. Erik Ekman holds the COO position in the company since the last four years. Erik has a solid experience in the pharmaceutical industry and has previouslyFärna Invest Increase Shareholding in Bluefish
PDF Document Attached FÄRNA INVEST INCREASES ITS SHAREHOLDING IN BLUEFISH PHARMACEUTICALS AB Färna Invest and Serendipity Partners have agreed that Färna Invest acquires Serendipity Partners' total shareholding in Bluefish Pharmaceuticals. “We are very pleased that we were able to increase our shareholding in Bluefish Pharmaceuticals. Our ambition is to prepare Bluefish Pharmaceuticals to be ready for an IPO within the next few years. We will continue to invest further into the company and contiSerendipity Bluefish Pharmaceuticals
“You’ll find it below in PDF Format www.bluefishpharma.comNotice to Annual General Meeting in Bluefish Pharmaceuticals AB (publ) - Swedish
Aktieägarna i Bluefish Pharmaceuticals AB (publ), org. nr. 556673–9164, (”Bolaget”) kallas härmed till årsstämma onsdagen den 19 maj 2021 Till följd av Covid-19 pandemin har styrelsen beslutat att årsstämman skall genomföras utan fysisk närvaro av aktieägare, ombud och utomstående och att utövande av rösträtt endast kan ske genom poströstning före årsstämman. REGISTRERING OCH ANMÄLAN För att ha rätt att deltaga genom poströstning i årsstämman ska aktieägare dels vara införd i den av Euroclear Sw
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bluefish Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Bluefish Pharmaceuticals, established in Sweden, specializes in providing affordable generic medications across Europe. The company is dedicated to ensuring quality pharmaceuticals remain accessible, focusing on market needs and efficiency to optimize investments and minimize development time. With a diverse portfolio of over 80 products, Bluefish... Read More
